Long-Term Complications of Native Valve Infective Endocarditis in Non-Addicts

Tornos, M.P.; Permanyer-Miralda, Gaietà; Olona, Montserrat; Gil, Miguel; Galve, Enrique; Almirante, Benito; Soler‐Soler, Jordi

doi:10.7326/0003-4819-117-7-567

Cited by 125 publications

(69 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Recent experiences in Europe have emphasized the potential for early valve repairs when feasible, especially in patients with anterior mitral valve IE and even in the absence of other conventional indicators for surgical interventions. 220 -222 This approach has a 2-fold potential benefit: Because Ͼ50% of patients with left-sided native valve IE will require valve replacement surgery within 10 to 15 years of the IE episode, 223 this "preemptive" repair strategy has the advantage of earlier-age intervention; and this approach may circumvent ultimate valve replacement requirements, with the attendant risks of long-term anticoagulation.…”

Section: Baddour Et Al Infective Endocarditis: Diagnosis and Managemementioning

confidence: 99%

Infective Endocarditis

Baddour¹,

Wilson²,

Bayer³

et al. 2005

Circulation

1,274

436

View full text Add to dashboard Cite

Background-Despite advances in medical, surgical, and critical care interventions, infective endocarditis remains a disease that is associated with considerable morbidity and mortality. The continuing evolution of antimicrobial resistance among common pathogens that cause infective endocarditis creates additional therapeutic issues for physicians to manage in this potentially life-threatening illness. Methods and Results-This work represents the third iteration of an infective endocarditis "treatment" document developed by the American Heart Association under the auspices of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease of the Young. It updates recommendations for diagnosis, treatment, and management of complications of infective endocarditis. A multidisciplinary committee of experts drafted this document to assist physicians in the evolving care of patients with infective endocarditis in the new millennium. This extensive document is accompanied by an executive summary that covers the key points of the diagnosis, antimicrobial therapy, and management of infective endocarditis. For the first time, an evidence-based scoring system that is used by the American College of Cardiology and the American Heart Association was applied to treatment recommendations. Tables also have been included that provide input on the use of echocardiography during diagnosis and treatment of infective endocarditis, evaluation and treatment of culture-negative endocarditis, and short-term and long-term management of patients during and after completion of antimicrobial treatment. To assist physicians who care for children, pediatric dosing was added to each treatment regimen. Conclusions-The recommendations outlined in this update should assist physicians in all aspects of patient care in the diagnosis, medical and surgical treatment, and follow-up of infective endocarditis, as well as management of associated complications. Clinical variability and complexity in infective endocarditis, however, dictate that these guidelines be used to support and not supplant physician-directed decisions in individual patient management. (Circulation. 2005; 111:e394-e433.)

show abstract

Section: Baddour Et Al Infective Endocarditis: Diagnosis and Managemementioning

confidence: 99%

Infective Endocarditis

Baddour¹,

Wilson²,

Bayer³

et al. 2005

Circulation

1,274

436

View full text Add to dashboard Cite

show abstract

“…Recaídas y recurrencias o la necesidad de una intervención quirúrgica luego del período intrahospitalario quedan fuera de los objetivos de este estudio, por lo que no se han consignado. Tornos et al 55 , en su serie publicada en 1992, estudiando EI en pacientes sin narcoadicción, muestra una sobrevida a 5 y 10 años de 88% y 81% respectivamente. Su estudio incluye el registro de sobrevida a 15 años y que llegó al 61% de sobrevida.…”

Section: Seguimientounclassified

“…Castillo et al 37 comunican 96% de sobrevida a 5 años para EI valvular nativa y de 82% para EIVP. La EI por drogadicción intravenosa no se incluye en estas dos series 37,55 . En nuestra casuís-tica sólo tuvimos 4 casos de EI por narcoadicción intravenosa (0,7%) por lo que estas dos series citadas pueden ser comparables con nuestra población.…”

Section: Seguimientounclassified

Endocarditis infecciosa: características clínicas, complicaciones y mortalidad en 506 pacientes y factores pronósticos de sobrevida a 10 años (1998-2008). Estudio cooperativo nacional en endocarditis infecciosa en Chile (ECNEI-2)

et al. 2012

View full text Add to dashboard Cite

“…This peak may be explained by recurrence of endocarditis in a relatively large group of patients 5 that often requires repeated surgery, especially in prosthetic valve recipients. [15][16][17] The second and third replacement peaks coincide with the identification and publication of risk factors for outlet strut fracture in 1992 and the nationwide mailing of individual risk estimates to all Dutch cardiothoracic centers in 1998, respectively. The consequences of disclosing such important information are now shown empirically.…”

Section: Discussionmentioning

confidence: 99%

Decision Guidelines for Prophylactic Replacement of Björk-Shiley Convexo-Concave Heart Valves

2004

View full text Add to dashboard Cite

Background-Because of risk of outlet strut fracture, prophylactic replacement should be considered for Björk-Shiley convexo-concave (BScc) valve recipients. We assessed the effects of epidemiological and decision-analytic guidelines on actual BScc valve replacement. Methods and Results-We performed a retrospective cohort study including all 2263 Dutch BScc patients with a mean follow-up of 11.3 years (range, 0 to 23 years). Outcomes were outlet strut fracture, mortality, and BScc valve replacement. For the surviving patients in 1992 (nϭ1330), we calculated the expected differences in life expectancy (LE) with and without BScc valve replacement according to decision guidelines developed in 1992. Differences in LE were compared with actual replacements. During 8 years of follow-up, there were 494 deaths (40%), and 11 patients had suffered outlet strut fracture. Of 1330 patients, 96 (10%) had undergone BScc valve replacement, particularly in years after introduction of initial and updated guidelines. One hundred seventeen patients (9%) had an estimated gain in LE after BScc valve replacement. These patients were more likely to undergo replacement than patients with an estimated loss of LE (hazard ratio, 6.6; 95% CI, 4.4 to 10; PϽ0.0001). A loss in LE after reoperation was predicted for 8 of 11 patients who experienced outlet strut fracture after guidelines were available. Conclusions-Valve replacement for BScc heart valve patients was largely in concordance with guidelines in the Netherlands. Individualized guidelines that are based on high-quality epidemiological data and are updated and implemented rigorously can influence clinical practice in complex decision problems.

show abstract

Long-Term Complications of Native Valve Infective Endocarditis in Non-Addicts

Cited by 125 publications

References 17 publications

Infective Endocarditis

Infective Endocarditis

Endocarditis infecciosa: características clínicas, complicaciones y mortalidad en 506 pacientes y factores pronósticos de sobrevida a 10 años (1998-2008). Estudio cooperativo nacional en endocarditis infecciosa en Chile (ECNEI-2)

Decision Guidelines for Prophylactic Replacement of Björk-Shiley Convexo-Concave Heart Valves

Contact Info

Product

Resources

About